15. Many large integrated delivery networks have a common electronic medical record system… A researcher wants to determine if the clinical outcomes for a chronic disease over a three-year period are better… Which research methodology will achieve this goal?
Answer: C
Cohort study
A cohort study is the most appropriate research methodology for determining if the clinical outcomes for a chronic disease improve over a three-year period. This approach allows researchers to observe and compare outcomes between a group of individuals exposed to a particular treatment or condition and a control group that is not.
A) Randomized control trial
A randomized control trial (RCT) is designed to assess the effectiveness of an intervention by randomly assigning participants to either the treatment or control group. While RCTs are powerful for establishing causation, they may not be feasible in this context, especially when observing long-term outcomes in a chronic disease over several years.
B) Case study
A case study focuses on an in-depth analysis of an individual or a small group, providing detailed qualitative insights. However, it lacks the statistical power to generalize findings to a larger population or to demonstrate changes over time in clinical outcomes for chronic diseases.
C) Cohort study
A cohort study allows researchers to track a group of individuals over time, observing their clinical outcomes related to a chronic disease. This methodology is particularly suited for analyzing changes in health status and can effectively highlight differences in outcomes related to specific exposures or treatments over a defined period.
D) Pre/post-study
A pre/post-study design involves measuring outcomes before and after an intervention but does not account for other variables that might influence the results over time. This approach may provide limited insight into long-term outcomes and lacks the comparative aspect of a cohort study.
Conclusion
The cohort study is the most effective choice for evaluating long-term clinical outcomes in chronic diseases, as it allows for the comparison of outcomes over time and can control for various confounding factors. In contrast, the other methodologies either lack the necessary framework for longitudinal analysis or do not provide sufficient generalizability and depth of insight into the population being studied.